Velika Britanija - engleski - MHRA (Medicines & Healthcare Products Regulatory Agency)

phoenix healthcare distribution ltd - glimepiride - oral tablet - 1mg

Velika Britanija - engleski - MHRA (Medicines & Healthcare Products Regulatory Agency)

waymade healthcare plc - glimepiride - oral tablet - 1mg

Novi Zeland - engleski - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - laronidase 0.58 mg/ml (rch) - concentrate for infusion - 500 u/5ml - active: laronidase 0.58 mg/ml (rch) excipient: dibasic sodium phosphate monobasic sodium phosphate monohydrate polysorbate 80 sodium chloride water for injection - aldurazyme is indicated as long-term enzyme replacement therapy in patients with mucopolysaccharidosis i (mps i; alpha-l-iduronidase deficiency) to treat the non-neurological manifestations of the disease.

Australija - engleski - Department of Health (Therapeutic Goods Administration)

juno pharmaceuticals pty ltd - darunavir, quantity: 800 mg - tablet, film coated - excipient ingredients: silicified microcrystalline cellulose; macrogol 4000; sodium chloride; iron oxide red; purified talc; titanium dioxide; hyprolose; crospovidone; polacrilin potassium; magnesium stearate; colloidal anhydrous silica; polyvinyl alcohol - adult patients,darunavir juno (with low dose ritonavir as a pharmacokinetic enhancer) is indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus-1 (hiv-1) infection in adult patients.,paediatric patients,darunavir juno (with low dose ritonavir as a pharmacokinetic enhancer) is indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus (hiv) infection in treatment-experienced paediatric patients aged 6 years and older, weighing at least 20 kg.

Australija - engleski - Department of Health (Therapeutic Goods Administration)

juno pharmaceuticals pty ltd - darunavir, quantity: 600 mg - tablet, film coated - excipient ingredients: crospovidone; magnesium stearate; purified talc; polyvinyl alcohol; hyprolose; polacrilin potassium; macrogol 4000; sodium chloride; titanium dioxide; iron oxide red; silicified microcrystalline cellulose; colloidal anhydrous silica; iron oxide yellow - adult patients,darunavir juno (with low dose ritonavir as a pharmacokinetic enhancer) is indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus-1 (hiv-1) infection in adult patients.,paediatric patients,darunavir juno (with low dose ritonavir as a pharmacokinetic enhancer) is indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus (hiv) infection in treatment-experienced paediatric patients aged 6 years and older, weighing at least 20 kg.

Australija - engleski - Department of Health (Therapeutic Goods Administration)

juno pharmaceuticals pty ltd - darunavir, quantity: 400 mg - tablet, film coated - excipient ingredients: sodium chloride; hyprolose; macrogol 4000; titanium dioxide; crospovidone; polacrilin potassium; iron oxide red; colloidal anhydrous silica; iron oxide yellow; purified talc; silicified microcrystalline cellulose; polyvinyl alcohol; magnesium stearate - adult patients,darunavir juno (with low dose ritonavir as a pharmacokinetic enhancer) is indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus-1 (hiv-1) infection in adult patients.,paediatric patients,darunavir juno (with low dose ritonavir as a pharmacokinetic enhancer) is indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus (hiv) infection in treatment-experienced paediatric patients aged 6 years and older, weighing at least 20 kg.

Singapur - engleski - HSA (Health Sciences Authority)

novem healthcare pte ltd - orthopaedics - pain and decreased articular mobility associated with degenerative lesions of the knee and other synovial joints, including osteoarthritis.

Australija - engleski - APVMA (Australian Pesticides and Veterinary Medicines Authority)

kd plant care pty ltd - glufosinate-ammonium - soluble concentrate - glufosinate-ammonium organophosphorus-phosphinic ac active 200.0 g/l - herbicide

Australija - engleski - APVMA (Australian Pesticides and Veterinary Medicines Authority)

kd plant care pty ltd - fluazifop-p present as the butyl ester; hydrocarbon solvent - emulsifiable concentrate - fluazifop-p present as the butyl ester phenoxy acids-propionics active 212.0 g/l; hydrocarbon solvent solvent other 636.0 g/l - herbicide

Australija - engleski - APVMA (Australian Pesticides and Veterinary Medicines Authority)

kd plant care pty ltd - tebuconazole - water dispersible granule - tebuconazole triazole active 750.0 g/kg - fungicide